Immunocore Holdings plc (IMCR) Tops Q3 EPS by 10c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q3 EPS of ($0.14), $0.10 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $45.87 million versus the consensus estimate of $32.82 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c